Assessment of functional immune responses

Clinical Immunology: Principles and Practice: Fourth Edition

Volumn , Issue , 2013, Pages 1172-1182

  Bleesing, Jack J H ^a   Oliveira, João B ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84943250154     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7234-3691-1.00108-2     Document Type: Chapter

References (60)

1. Bleesing J.J., Fleisher T.A. Immunophenotyping. Semin Hematol 2001, 38:100-110.
2. Stobo J.D. Phytohemagglutin and concanavalin A: probes for murine 'T' cell activivation and differentiation. Transplant Rev 1972, 11:60-86.
3. Greaves M., Janossy G., Doenhoff M. Selective triggering of human T and B lymphocytes in vitro by polyclonal mitogens. J Exp Med 1974, 140:1-18.
4. Vine J.B., Geppert T.D., Lipsky P.E. T4 cell activation by immobilized phytohemagglutinin: differential capacity to induce IL-2 responsiveness and IL-2 production. J Immunol 1988, 141:2593-2600.
5. Geppert T.D., Lipsky P.E. Activation of T lymphocytes by immobilized monoclonal antibodies to CD3. Regulatory influences of monoclonal antibodies to additional T cell surface determinants. J Clin Invest 1988, 81:1497-1505.
6. Flomenberg N., Welte K., Mertelsmann R., et al. Immunologic effects of interleukin 2 in primary immunodeficiency diseases. J Immunol 1983, 130:2644-2650.
7. Chan A.C., Kadlecek T.A., Elder M.E., et al. ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science 1994, 264:1599-1601.
8. Gordon E.H., Krouse H.A., Kinney J.L., et al. Delayed cuteneous hypersensitivity in normals: choice of antigens and comparison to in vitro assays of cell-mediated immunity. J Allergy Clin Immunol 1983, 72:487.
9. Palmer D.L., Reed W.P. Delayed hypersensitivity skin testing. II. J Infect Dis 1974, 130:138.
10. Roberts K., Lotze M.T., Rosenberg S.A. Separation and functional studies of the human lymphokine-activated killer cell. Cancer Res 1987, 47(16):4366-4371.
11. Whiteside T.L., Vujanovic N.L., Herberman R.B. Natural killer cells and tumor therapy. Curr Top Microbiol Immunol 1998, 230:221-244.
12. Sanderson C.J. The mechanism of lymphocyte-mediated cytoxicity. Biol Rev 1981, 56:153-197.
13. Rees R.C. MHC-restricted and nonrestricted killer lymphocytes. Blood 1990, 4:204-210.
14. Greenberg A.H., Shen L.A. Class of specific cytotoxic cells demonstrated in vitro by arming with antigen-antibody complexes. Nat New Biol 1973, 245:282-285.
15. Johnson W.J., Steplewski Z., Matthews T.J., et al. Cytolytic interactions between murine macrophages, tumor cells, and monoclonal antibodies: Characterization of lytic conditions and requirements for effector activation. J Immunol 1986, 136:4707-4713.
16. Melder R.J., Walker E.R., Herberman R.B., Whiteside T.L. Surface characteristics, morphology, and ultrastructure of human adherent lymphokine-activated killer cells. J Leukoc Biol 1990, 48:163-173.
17. Melder R.J., Walker E., Herberman R.B., et al. Adhesion characteristics of human interleukin 2-activated natural killer cells. Cell Immunol 1991, 132:177-192.
18. Berke G. The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Annu Rev Immunol 1994, 12:735-773.
19. Russell J.H., Ley T.J. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 2002, 20:323-370.
20. Podack E.R., Hengarner H., Lichtenheld M.G. A central role of perforin in cytolysis?. Annu Rev Immunol 1991, 9:129-157.
21. Brunner T., Wasem C., Torgler R., et al. Fas (CD95/Apo-1) ligand regulation in T cell homeostasis, cell-mediated cytotoxicity and immune pathology. Semin Immunol 2003, 15:167-176.
22. Whiteside T.L., Bryant J., Day R., Herberman R.B. Natural killer cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay. J Clin Lab Anal 1990, 4:102-114.
23. Whiteside T.L., Herberman R.B. Role of human natural killer cells in health and disease. Clin Diagn Lab Immunol 1994, 1:125-133.
24. Sullivan K.E., Delaat C.A., Douglas S.D., Filipovich A.H. Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives. Pediatr Res 1998, 44:465-468.
25. Villanueva J., Lee S., Giannini E.H., et al. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther 2005, 7:R30-37.
26. Grom A.A., Villanueva J., Lee S., et al. Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr 2003, 142:292-296.
27. Bryant J., Day R., Whiteside T.L., et al. Calculation of lytic units for the expression of cell-mediated cytotoxicity. J Immunol Methods 1992, 146:91-103.
28. Junghans R.P., Waldmann T.A., Landolfi N.F., et al. Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disorders. Cancer Res 1990, 50:1495-1502.
29. Sorensen R.U., Moore C. Antibody deficiency syndromes. Pediatr Clin North Am 2000, 47(6):1225.
30. Bleesing J.J., Fleisher T.A. Human B cells express a CD45 isoform that is similar to murine B220 and is downregulated with acquisition of the memory B-cell marker CD27. Cytometry B Clin Cytom 2003, 51:1-8.
31. Avanzini M.A., Locatelli F., Dos Santos C., et al. B lymphocyte reconstitution after hematopoietic stem cell transplantation: functional immaturity and slow recovery of memory CD27+ B cells. Exp Hematol 2005, 33:480-486.
32. Stiehm E.R., Ochs H.D., Winkelsein J.A. Immunodeficiency disorders: general considerations. Immunologic disorders in infants and children 2004, Elsevier Saunders, Philadelphia, PA. 5th ed. E.R. Stiehm, H.D. Ochs, J.A. Winkelsein (Eds.).
33. Pyuan K.H., Ochs H.D., Wedgwood R.J., et al. Human antibody responses to bacteriophage phiX174: sequential induction of IgM and IgG subclass antibody. Clin Immunol Immunopathol 1989, 51:252-263.
34. Curtis J.E., Hersh E.M., Harris J.E., et al. The human primary immune response to keyhole limpet haemocyanin: interrelationships of delayed hypersensitivity. Clin Exp Immunol 1970, 6:473.
35. Brinkman D.M., der Zijde CM Jol-van, ten Dam M.M., et al. Vaccination with rabies to study the humoral and cellular immune response to a T-cell dependent neoantigen in man. J Clin Immunol 2003, 23:528-538.
36. Orange J.S., Levy O., Geha R.S. Human disease resulting from gene mutations that interfere with appropriate nuclear factor-kappaB activation. Immunol Rev 2005, 203:21-37.
37. Picard C., von Bernuth H., Ghandil P., et al. Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine (Baltimore) 2010, 89:403-425.
38. Picard C., Casanova J.L., Puel A. Infectious diseases in IRAK-4, MyD88, NEMO or IkBa deficiency. Clin Microbiol Rev 2011, 24(3):490-497.
39. von Bernuth H., Ku C.L., Rodriguez-Gallego C., et al. A fast procedure for the detection of defects in Toll-like receptor signaling. Pediatrics 2006, 118:2498-2503.
40. Rosenzweig S.D., Holland S.M. Defects in the interferon-gamma and interleukin-12 pathways. Immunol Rev 2005, 203:38-47.
41. Haverkamp M.H., van Dissel J.T., Holland S.M. Human host genetic factors in nontuberculous mycobacterial infection: lessons from single gene disorders affecting innate and adaptive immunity and lessons from molecular defects in interferon-gamma-dependent signaling. Microbes Infect 2006, 8:1157-1166.
42. Hambleton S., Salem S., Bustamante J., et al. IRF8 Mutations and Human Dendritic-Cell Immunodeficiency. N Engl J Med 2011, 365(2):127-138.
43. Oliveira J.B., Notarangelo L.D., Fleisher T.A. Applications of flow cytometry for the study of primary immune deficiencies. Curr Opin Allergy Clin Immunol 2008, 8:499-509.
44. Hanna S., Etzoni A. New host defense mechanisms against Candida species clarify the basis of clinical phenotypes. J Allergy Clin Immunol 2011, 127(6):1433-1437.
45. Glocker E.O., Hennigs A., Nabavi M., et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 2009, 361:1727-1735.
46. Minegishi Y., Saito M., Tsuchiya S., et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 2007, 448:1058-1062.
47. Puel A., Cypowyj S., Bustamante J., et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 2011, 332:65-68.
48. de Beaucoudrey L., Puel A., Filipe-Santos O., et al. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med 2008, 205:1543-1550.
49. Bidere N., Su H.C., Lenardo M.J. Genetic disorders of programmed cell death in the immune system. Annu Rev Immunol 2006, 24:321-352.
50. Bleesing J.J. Autoimmune lymphoproliferative syndrome (ALPS). Curr Pharm Des 2003, 9:265-278.
51. Snow A.L., Marsh R.A., Krummey S.M., et al. Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency. J Clin Invest 2009, 119:2976-2989.
52. Niemela J.E., Lu L., Fleisher T.A., et al. Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis. Blood 2011, 117:2883-2886.
53. Chatila T.A. Role of regulatory T cells in human diseases. J Allergy Clin Immunol 2005, 11:949-959.
54. Wildin R.S., Smyk-Pearson S., Filipovich A.H. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2002, 39:537-545.
55. Ahmed F., Friend S., George T.C., et al. Numbers matter: quantitative and dynamic analysis of the formation of an immunological synapse using imaging flow cytometry. J Immunol Methods 2009, 347:79-86.
56. Bossi G., Trambas C., Booth S., et al. The secretory synapse: the secrets of a serial killer. Immunol Rev 2002, 189:152-160.
57. Tolar P., Pierce S.K. A conformation-induced oligomerization model for B cell receptor microclustering and signaling. Curr Top Microbiol Immunol 2010, 340:155-169.
58. Maguire O., Collins C., O'Loughlin K., et al. Quantifying nuclear p65 as a parameter for NFκB activation: Correlation between ImageStream cytometry, microscopy, and Western blot. Cytometry A 2011, 79(6):461-469.
59. Ploppa A., George T.C., Unertl K.E., et al. ImageStream cytometry extends the analysis of phagocytosis and oxidative burst. Scand J Clin Lab Invest 2011, 71(5):362-369.
60. Ouk C., Jayat-Vignoles C., Donnard M., Feuillard J. Both CD62 and CD162 antibodies prevent formation of CD36-dependent platelets, rosettes, and artefactual pseudoexpression of platelet markers on white blood cells: A study with ImageStream(®). Cytometry A 2011, 79(6):477-484.